Command Palette

Search for a command to run...

PodMine

Norwegian Sovereign Wealth Fund

Matches in: Organization
5 episodes
Dec 24, 2025• In Good Company with Nicolai Tangen

Saul Perlmutter: The Accelerating Universe, Doubt as a Superpower and the Science of Collaboration

Nobel Prize-winning physicist Saul Perlmutter discusses the power of scientific thinking, collaboration, doubt, and the importance of critical thinking in navigating an increasingly complex and uncertain world.

1:00:32
Nov 12, 2025• In Good Company with Nicolai Tangen

Novonesis CEO: Biosolutions at Scale, Replacing Chemicals and Leading for a Healthier Planet

Nicolai Tangen interviews Ester Baiget, CEO of Novonesis, about how the company uses fermentation and biotechnology to create natural, sustainable alternatives to chemicals in industries ranging from food and dairy to detergents and biofuels.

46:48
Nov 5, 2025• In Good Company with Nicolai Tangen

DBS CEO: Transforming Southeast Asian Banking, Embracing Diversity and Balancing AI with Humanity

In an intimate conversation, DBS CEO Tan Su Shan discusses the bank's digital transformation, Singapore's success story, and her leadership philosophy, emphasizing the importance of embracing AI while maintaining human connection and staying curious about emerging trends.

56:35
Oct 15, 2025• In Good Company with Nicolai Tangen

Sea CEO: Gaming Empire, Southeast Asia Strategy and Humble Leadership

Forrest Li, founder and CEO of Sea, shares the inspiring journey of building Southeast Asia's largest tech company across gaming, e-commerce, and fintech, emphasizing humility, technology, and customer-centric innovation.

50:16
Sep 5, 2025• In Good Company with Nicolai Tangen

HIGHLIGHTS: Sir David Spiegelhalter

Sir David Spiegelhalter, a renowned statistician, discusses the importance of understanding uncertainty, evidence-based decision-making, and the role of data during crises like the COVID-19 pandemic. He shares personal insights about communicating risk, the challenges of medical statistics, and his own experience with prostate cancer, emphasizing the need to respect and understand data.

0:10